atrial fibrillation and heart failure€¦ · 12.10 atrial fibrillation in endurance athletes l....

Atrial Fibrillation and Heart Failure::the ugly and the nasty

February 16/17, 2017

Royal Hotel Carlton, Bologna - Italy

1

Xxxxxxxxxxxxxxxx

AtAtAtririr al Fibrillation and Heart Failure::the ugly and the nasty

Feebe ruauauarry r 16/17, 2017

Royooyal aa Hoototel ee CarCarCarltonnn, BBologna - Italy

11

Xxxxxxxxxxxxxxxxxxxxxxxx

ATRIAL

FIBRILLATION

201712°INTERNATIONAL

MEETING

Atrial Fibrillationand Heart Failure:

the ugly and the nasty


Royal Hotel Carlton

Bologna - Italy

AF2017 BOLOGNA_finprg_0117.indd 1AF2017 BOLOGNA_finprg_0117.indd 1 07/02/17 07.1707/02/17 07.17

2

ATRIAL

FIBRILLATION


MEETING

PRESIDENT

Alessandro Capucci, MD

Cardiology Clinic

Ospedali Riuniti Le Torrette

Università Politecnica delle Marche

Ancona - Italy

[email protected]

Under the patronage of

Organizing Secretariat

Bk1 conceptFactory

Corso Matteotti 200

51016 Montecatini Terme (PT)

tel. +39 0572 911864

fax +39 0572 904259

mail: [email protected]

www.bk1.it/scientifi c-events





3

Biffi M. (Bologna, I)

Boriani G. (Modena, I)

Botto G.L. (Como, I)

Brachmann J. (Coburg, D)

Calò L. (Rome, I)

Calvi V. (Catania, I)

Cappato R. (Bergamo - Rozzano, I)

Capucci A. (Ancona, I)

Cascinu S. (Modena, I)

Cipriano A. (Pisa, I)

Curnis A. (Brescia, I)

De Caterina R. (Chieti, I)

De Maria E. (Carpi,I)

De Ponti R. (Varese, I)

Del Greco M. (Rovereto, I)

Della Bella P. (Milan, I)

Di Biase M. (Bari, I)

Di Pasquale G. (Bologna, I)

D’Onofrio A. (Napoli, I)

Favale S. (Bari, I)

Grigioni F. (Bologna, I)

Grimaldi M. (Acquaviva delle Fonti, I)

Guerra F. (Ancona, I)

Ho Y. (London, UK)

Iacopino S. (Cotignola, I)

Jung W. (Villingen Schwenningen, D)

Kaitani K. (Nara, J)

Le Heuzey J.Y. (Paris, FR)

Leoni P. (Ancona, I)

Lévy S. (Marseilles, FR)

Lewalter T. (Bonn, D)

Loforte A. (Bologna, I)

Lombardi F. (Milan, I)

Lüderitz B. (Bonn, D)

Lunati M. (Milan, I)

Maglia G.P. (Catanzaro, I)

Mantovan R. (Cesena, I)

Marini M. (Trento, I)

Mascioli G. (Bergamo)

Maurea N. (Naples, I)

Mont L. (Barcelona, E)

Naccarelli G.V. (Hershey, USA)

Nattel S. (Quebec, CDN)

Padeletti L. (Florence, I)

Perrone Filardi P. (Naples, I)

Rapacciuolo A. (Napoli, I)

Rapezzi C. (Bologna, I)

Raviele A. (Mestre, I)

Ricci R.P. (Rome, I)

Rovaris G. (Monza, I)

Salerno-Uriarte J.A. (Varese, I)

Sediva L. (Prague, CZ)

Tamargo J. (Madrid, E)

Tomasi C. (Ravenna, I)

Tondo C. (Milan, I)

Torp-Pedersen C. (Copenaghen, DK)

Ussia G.P. (Rome, I)

Wilde A. (Amsterdam, NL)

Zanon F. (Rovigo, I)

Zanotto G. (Legnago, I)

Ziacchi M. (Bologna, I)

Zingarini G. (Perugia, I)

Faculty


4

ATRIAL

FIBRILLATION


MEETING

8.00 Registration

8.45 Opening Ceremony

New developments in Atrial Fibrillation/Heart Failure

Chairmen: B. Luderitz - C. Rapezzi

9.00 Anatomical perspectives relevant to Atrial Fibrillation

Y. Ho

9.20 Atrial Fibrillation and fi brosis: still a strict link?

J. Brachmann

9.40 Does genetic testing play a role in treatment decisions in Atrial

Fibrillation?

A. Wilde

10.00 How long is the optimal Atrial Fibrillation duration?

G. Boriani

10.20 The role if Telemedicine in implantable device for Heart Failure

and its therapeutic impact: Lesson from IN-TIME Study

G. Zanotto

10.40 Coffee break and Poster Session

Thursday February 16, 2017Scientifi c Program





5

Thursday February 16, 2017

The Cardioncology Affair

Chairmen: S. Lévy - A. Raviele

11.00 Atrial Fibrillation, Heart Failure and cancer: how do they interact? W. Jung

11.20 Atrial Fibrillation and QT prolongation in cancer patients N. Maurea

11.40 How to better evaluate the QT in cardioncology F. Lombardi

12.00 Is EF still the best parameter to evaluate? F. Guerra

12.20 How to organize the optimal follow up S. Cascinu

12.40 New anti-leukemic treatments deserve a cardioncology approach P. Leoni

13.15-14.15 Luncheon panel session in dedicated Meeting room


6

ATRIAL

FIBRILLATION


MEETING


Atrial Fibrillation: how hypo-coagulate and when

Chairmen: V. Calvi - G. Naccarelli

14.40 History of Anticoagulation - From the Beginning to Direct Oral Anticoagulants

B. Lüderitz

15.00 Why high risk Atrial Fibrillation patients are not taking anticoagulants? An electronic medical record solution to the issue

G. Naccarelli

15.20 Cardiac Rhythm detailed monitoring by an implanted pacemaker: the iECG solution

F. Zanon

15.40 How to avoid complication during PVI L. Sediva

16.00 NOACs in ECV and ablation therapies R. Cappato

16.20 The impact of LV diastolic function in AF ablation cases - Lessons from KPAF registry

K. Kaitani





7


Nao or Never

Chairmen: S. Favale - R. Mantovan

16.40 Apixaban: from the clinical trials to the real life experiences G. Di Pasquale

17.00 State of art in anticoagulation in non valvular Atrial Fibrillation: the additional value of Rivaroxaban real life data

M. Grimaldi

17.20 Dabigatran: a large experience on the fi eld P. Perrone Filardi

17.40 Does Edoxaban add anything new? R. De Caterina

18.00 Meeting Debate in dedicated room New Technology for HF Patients


8

ATRIAL

FIBRILLATION


MEETING

Friday February 17, 2017

Antiarrhythmic drugs in Atrial Fibrillation:

still a challenge

Chairmen: M. Di Biase - J.Y. Le Heuzey

9.00 Role of 1C AAD Revisited

J. Tamargo

9.20 Role of class 3 AAD Revisited

J.Y. Le Heuzey

9.40 Do new AAD add anything useful to common practice?

C. Torp-Pedersen

10.00 When and how to apply rate control therapy

G.L. Botto

10.20 Coffee break and Poster Session





9


Atrial Fibrillation prognostic implications

Chairmen: A. Curnis - S. Nattel

10.50 Paroxysmal and persistent Atrial Fibrillation:

are there clinical differences?

S. Levy

11.10 Subclinical Atrial Fibrillation: the next 5 years

R. De Ponti

11.30 First degree AV block: a benign condition or an indication for

continuous monitoring?

T. Lewalter

11.50 Atrial Cardiomyopathy, a new concept. How does it help?

S. Nattel

12.10 Atrial Fibrillation in endurance athletes

L. Mont

12.30 Ronald Campbell Lecture

Atrial Fibrillation: fi xed and still changeable opinions

A. Capucci

Introducing by

S. Nattel

13.20-14.20 Luncheon panel session in dedicated Meeting room


10

ATRIAL

FIBRILLATION


MEETING


Atrial Fibrillation Ablation and related procedures

Chairmen: R.P. Ricci - L. Mont

14.40 LAA occlusion: how and when

G.P. Ussia

15.00 A Cryo anatomical procedure to everyone?

S. Iacopino

15.20 Rotors are the clue

C. Tondo

15.40 High quality signal in arrhythmic substrate

P. Della Bella

16.00 How to follow up the patients after ablation

L. Calò

16.20 Selected Poster: oral presentation

16.40 Awards for poster presenters

Board Commission:

A. Capucci - G. Boriani - T. Lewalter

17.00 Closing & Remarks





Royal Hotel Carlton

Bologna - Italy

Luncheon panel

and Meeting session

in dedicated room


12

ATRIAL

FIBRILLATION


MEETING


13.15-14.15 Luncheon Panel Medtronic’s Room

Atrial Fibrillation: detect timely to treat appropriately

Chairmen: F. Lombardi - S. Favale

Ablation of AF: a simplify approach to treat earlier and improve

outcome

S. Iacopino

Heart Failure and AF: bidirectional causality and opportunistic

fi ndings from implantable cardiac devices

G. Boriani

Stroke and AF: silent episode detection is crucial to optimize

therapy and prevent recurrence

G. Rovaris


Atrial Fibrillation and Heart Failure:the ugly and the nasty



13


13.15-14.15 Luncheon Panel Biotronik’s Room

Hot Topics in electrical treatment of Heart Failure and

Atrial Fibrillation

Chairmen: M. Lunati - A. D’Onofrio

Heart Failure in ICD population: Does exist an unique parameter

to predict heart failure worsening?

What can we learn from Selene Study?

L. Padeletti

New options in Cardiac Resynchronization Therapy: use, perfor-

mance and research projects on CRTD- DX system

M. Biffi

DDD/AAI switch algorithm in sinus disease: the right function to

prevent unnecessary ventricular pacing?

Lessons from VIPERS Study

V. Calvi

Home Monitoring and mortality reduction: the evidence from the

trials

G. Zanotto


14

ATRIAL

FIBRILLATION


MEETING


13.15-14.15 Luncheon Panel Boehringer Ingelheim’s Room

Interactive discussion on clinical practice

in Atrial Fibrillation

Dabigatran and other oral anticoagulants & procedures

A. Cipriano, F. Guerra, M. Ziacchi





15


18.00-19.00 Meeting Debate Abbott’s Room

St. Jude Medical is now Abbott

New Technology for HF Patients

A. Capucci, F. Grigioni, A. Loforte, M. Lunati

The session is a debate among experts on Heart Failure to discuss how

technology could help HF patient, his outcome and his quality of life. The

involved experts are from different area of the Heart Failure (clinician,

electrophisiology, cardiosurgery) in order to have different points of view

on this complex topic


16

ATRIAL

FIBRILLATION


MEETING


13.20-14.20 Luncheon Panel Boston Scientifi c’s Room

Rhythmia, S-ICD and Smart CRT therapy

Chairmen: M. Del Greco - C. Tomasi

New high defi nition technology: can it improve the AF treatment?

G. Zingarini

Therapy adoption and S-ICD automatic screening tool

M. Biffi

Personalized solution to optimize CRT patient

M. Marini





17


13.20-14.20 Luncheon Panel Livanova’s Room

Improving outcomes in HF Patients

Chairmen: G. Mascioli - L. Calò

HF and AF management: calling for Sleep Apnea screening

A. Rapacciuolo

Discussion

Clinical impact of CRT optimization

F. Zanon

Discussion

New paradigm to pace patients with AV conduction disorders

E. De Maria

Discussion


18

ATRIAL

FIBRILLATION


MEETING


13.20-14.20 Luncheon Panel Bruno Farmaceutici’s Room

Role of Flecainide in the management of Atrial Fibrillation

and the new strategies to improve the control of rhythm

Atrial Fibrillation and Rhythm Control. Role of pharmacological

and non-pharmacological treatment

J.A. Salerno - Uriarte

Atrial Fibrillation and non-adherence to therapy as a possible risk

factor

V. Calvi

Pharmacological Innovation to improve management of therapy:

the Flecainide controlled release and its effi cacy and safety profi le

G.P. Maglia

Ercaf Study: Update and state of art

F. Guerra





19

Poster

1) DO CLASS 1C AGENTS HAVE A ROOM IN TERMINATING RECENT-ONSET ATRIAL FIBRILLATION IN ELDERLY PEOPLE?

A. Bonora1, G. Turcato1, V. Siviero1, G. Zerman1, G. Ricci1, C. Pistorelli1 1Verona, ITALY

2) DIFFERENTIAL EFFECTS OF FACTOR XA INHIBITORS RIVAROXABAN AND APIXABAN VS THE DIRECT THROMBIN INHIBITOR DABIGATRAN ON PLATELET FUNCTION

V. Bucciarelli1, T. Salvatore1, P. Lanuti1, M. Marchisio1, R. De Caterina1, G. Renda1

1Chieti, ITALY

3) RISK FACTORS OF CIED INFECTION ALSO PREDICT POST-EXTRACTION OUTCOMES AT LONG TERM

I. Diemberger1, M. Biffi 1, S. Lorenzetti1, C. Martignani1, G. Massaro1, M. Ziacchi1, G. Boriani1 1Bologna, ITALY

4) ESTIMATING CHRONIC KIDNEY DISEASE IN THE REAL WORLD: WHAT IMPLICATIONS ON DECISION MAKING ON ANTICOAGULATION ACCORDING TO DIFFERENT EQUATIONS FOR ASSESSING RENAL FUNCTION?

E. Fantecchi1, V. Malavasi1, F. Pesce1, C. Zoccali1, S. Arrotti1, G. Boriani1 1Modena and Reggio Emilia, ITALY

5) NEW STUDIES OFFER INCREASED SAFETY DURING AF ABLATION BY MONITORING ESOPHAGEAL TEMPERATURE

A. Fasano1

1Firenze, ITALY

6) COMPARISON BETWEEN BASELINE CHARACTERISTICS IN ITALY OF PATIENTS TREATED WITH STANDARD THERAPY AND NOAC ENROLLED IN REGISTRIES PREVENTION OF THROMBOEMBOLIC EVENTS - EUROPEAN REGISTRY IN ATRIAL FIBRILLATION (PREFER IN AF) AND PREFER IN AF PROLONGATION

F. Guerra1, P. Bonelli1, A. Bonaccorsi2, M. Manu2, G. Renda3, R. De Caterina3, A. Capucci1 1Ancona, 2Roma, 3Chieti, ITALY

7) ATRIAL FIBRILLATION IN CARDIOLOGIC PRACTICE: A PROSPECTIVE MONOCENTRIC REGISTRY ANALYSIS AND A 3 YEARS OUTCOME EVALUATION RELATED TO STANDARD ECHOCARDIOGRAPHIC PARAMETERS

R. Mei1, L. Bianchini1, C. Martignani1, M. Biffi 1, M. Ziacchi1, G. Massaro1, S. Lorenzetti1, M. Gallucci 1, K. Valentino 1, J. Frisoni1, G. Boriani2, I. Diemberger1

1Bologna, 2Modena, ITALY

8) NOVEL ORAL ANTICOAGULANTS (NOACS) FOR THROMBOEMBOLIC EVENTS PREVENTION IN PATIENTS WITH NON VALVULAR ATRIAL FIBRILLATION: REAL WORLD EXPERIENCE OF A THIRD LEVEL CARE CENTRE

F. Melillo1, L. Arrigoni1, M. Cera1, A. Salerno1, A. Monello1, A. Scotti1, C. Pivato1, C. Ballarotto1, M. Oppizzi1, M. Slavich1, R. Spoladore1, G. Fragasso1, A. Cappelletti1, C. Godino1, A. Margonato1

1Milano, ITALY

9) IAB IS REAL. A CASE OF BAYÉS SYNDROME DEVELOPMENT AFTER THE FIRST DIALYTIC SESSION

G. Mussatti1, A. Vecchiato1

1Sassari, ITALY


20

10) ANTICOAGULATION IN ATRIAL FIBRILLATION – A SINGLE-CENTRE AUDIT ON PATIENT EDUCATION, STROKE AND BLEEDING RISK ASSESSMENTS AND USE OF DIRECT ORAL ANTICOAGULANTS (DOACS)

N. Sher May1, J. Bindumol2, S. Amarjit2

1Lewisham and Greenwich, 2London, UK

11) “SHOCKING” ASSOCIATION BETWEEN CHEST COMPRESSIONS AND VENTRICULAR FIBRILLATION RECURRENCES IN OUT-OF-HOSPITAL CARDIAC ARRESTS

E. Paolini1, D. Aschieri2, F. Guerra1, V. Pelizzoni2, G.Q. Villani2, S. Nani2, G.H. Bardy3, A. Capucci1 1Ancona, 2Piacenza, ITALY; 3Seattle, USA

12) GUIDELINE-ADHERENT ANTITHROMBOTIC TREATMENT IN PATIENTS WITH ATRIAL FIBRILLATION AND HEART FAILURE: A REPORT FROM THE RUSSIAN OBSERVATIONAL SURVEY (RIF-CHF)

N.V. Romanova1, F. Osmolovskayayu1, I.V. Zhirov1, S.N. Tereshchenko1, S.P. Golitsyn1

1Moscow, RUSSIA

13) ACCURACY AND OVERALL PERFORMANCE OF MYDIAGNOSTICK IN DETECTING INCIDENTAL ATRIAL FIBRILLATION DURING AN UNSELECTED POPULATION SCREENING: RESULTS OF THE RITMOK PROJECT

F. Troiano1, F. Guerra2, A. Capucci1 1Ancona, ITALY

14) ITALIAN EXPERIENCE IN PROTECTING PATIENTS AT HIGH RISK OF SUDDEN CARDIAC DEATH THROUGH THE USE OF THE WEARABLE DEFIBRILLATOR

E. Turri1, A. Sacchettini1 1Bologna, ITALY

Poster

ATRIAL

FIBRILLATION


MEETING





Royal Hotel Carlton

Bologna - Italy


22

Congress Venue

ATRIAL

FIBRILLATION


MEETING

MEETING VENUERoyal Hotel Carlton - Via Montebello 8 40121 BolognaTel. +39 051249361 - Fax +39 051249724 - e-mail [email protected]

HOW TO REACH THE MEETING VENUE The Royal Hotel Carlton is located in the city centre, close to the historic area. You can reach the venue:• By train: walking distance from the railway station• By aeroplane: the Bologna Airport is 30 minutes distant from the venue by taxi or airport bus transfer “Aerobus” (the bus stop is outside the airport, reaching the railway station and viceversa)• By car: from the motorway take the Ring Road (“Tangenziale”); Exit no. 7 “Bologna Centro”; you will arrive in Via Stalingrado, continue straight ahead into Via Mascarella; turn right into Via Irnerio and continue straight ahead until you come to a roundabout in Via dei Mille; then turn right into Via Gramsci taking the fi rst street on the right which is Via Montebello. The Conference Centre has private parking.To reach the hotel using satellite navigation, it should be set for Via Milazzo 6 to avoid the restricted traffi c zone





23

General Information

OFFICIAL LANGUAGE

English

SLIDES

Only PC data projection will be available in every room.

All slides must be worded in English only; please copy your work - prepared in

PowerPoint - on a CD or USB stick.

The Slide Centre will be available for presenters and speakers to preview their

slides and to become familiar with audio-visual equipment. Slides should be

handed in one hour before the beginning of the session and collected at the

end. The use of personal laptops in the Workshop room is not permitted.

LUNCH

Lunches will be served during the luncheon panels, limited to seat availability.

REGISTRATION - BADGE

The conference is open to all duly registered participants. A badge will be given

to every registered participant, speaker and exhibitor in order to be admitted

to the scientifi c sessions.

REGISTRATION FEE

Before December 19, 2016 After December 20, 2016

Medical Doctor € 507,00 € 730,00

Specialising MD* € 61,00 € 121,00

* please enclose a certifi cate of the registration in a postgraduate school

The registration fee includes the following:

- Admission to all Scientifi c Sessions

- Admission to the Exhibition

- Admission to Luncheon Panels

- Coffee break and snack lunch on each day

- Attendance and ECM certifi cate

- Italian VAT


24

General Information

ATRIAL

FIBRILLATION


MEETING

TRAVEL AGENCY Bk1

Please fi ll in the following hotel accommodation form and send it back to the

Organizing Secretariat Bk1 with the required payment.

We have selected several hospitality facilities with special room rates:

HOTEL RESERVATION

CATEGORY DOUBLE SINGLE USE DOUBLE

Hotel Carlton/

Meeting Venue € 159,00 € 179,00

4 stars from € 120,00 - to € 230,00 from € 160,00 - to € 300,00

3 stars from € 85,00 - to € 120,00 from € 110,00 - to € 160,00

Guarantee Required: the price of one night per room in the selected hotel

category, with B&B treatment (City Tax not included). The Hotel reservation will only be accepted and confi rmed when the form and the required

guarantee with credit card have been received by Bk1. All payments must be done in Euro

net of all bank charges and made out to Bk1

Air and Railway Tickets

Please do not hesitate to contact the Organizing Secretariat for any emission

of aerial and railway tickets and for other needs or information.

PAYMENT

Payment for Registration and Hotel Reservation should be done by:• Bank Transfer made out to Bk1

C/C: 1915/00 ABI: 06260 CAB: 70461

IBAN: IT65L0626070461000001915C00

SWIFT CODE (BIC): CRFI IT 3P – CIN L, please mention “AF2017”

Please send a copy of the bank transfer with the accommodation form to:

Bk1 Fax +39 (0)572 904259 or Email scientifi [email protected]

• Credit Card

❏ CartaSi ❏ Visa ❏ Diner’s ❏ Amex Card number________________________________

Cardholder name_____________________________________________ Expiration date____/_____

Date of birth____________________________________________________________________

Signature___________________________________________ Date ____________________

In case of written cancellation before December 19, 80% of the deposit will be refunded.





25

General Information

ABSTRACT & POSTERS

Best Communication / Poster Award

A special awards 1.500,00 euro gross will be given to the “Best Abstract”

works selected by the Abstract Selection Committee between accepted oral

communications and posters. The winners will be announced during the Best

Abstract Award event scheduled for the evening of 17 February 2017.

Posters will be displayed during the whole meeting in the Exhibition Area, they

should be fi xed on February 16, at 8.00 a.m. and removed at the end of the

meeting. Material for the poster mounting will be provided.

An award for the best poster selected among young authors (under 35 years)

will be given.

ATTENDANCE CERTIFICATE

A certifi cate will be given to all participants at the end of the meeting.

ECM

An application for Italian ECM Credits has been submitted to the Italian Ministry

of Health for the following disciplines: Cardiology, Cardio Surgery, General

Medicine (Family doctors), Internal Medicine.

SECRETARIAT

The Organizing Secretariat will be open during the whole Meeting.

CHANGES

For scientifi c and/or technical reasons the President of the Congress and

Organizing Secretariat reserve the right to make any change in the Program.

Updated information will be available on the web site www.bk1.it/scientifi c-events


26

ATRIAL

FIBRILLATION


MEETING

Thanks to





27

Thanks to


ATRIAL

FIBRILLATION


MEETING




Organizing Secretariat

Bk1 conceptFactory

Corso Matteotti 200

51016 Montecatini Terme (PT)

tel. +39 0572 911864

fax +39 0572 904259

mail: [email protected]

www.bk1.it/scientifi c-events


atrial fibrillation and heart failure€¦ · 12.10 atrial fibrillation in endurance athletes l....

Documents